Cleared Traditional

K060847 - MAGSTIM 200-2

K060847 is an FDA 510(k) clearance for MAGSTIM 200-2, manufactured by Magstim Company Us, LLC. The device is a Class 2 Neurology device with product code GWF cleared through the Traditional 510(k) pathway after a 182-day FDA review.

K060847 · Magstim Company Us, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2006
Decision
182d
Days
Class 2
Risk

K060847 is an FDA 510(k) clearance for the MAGSTIM 200-2. Classified as Stimulator, Electrical, Evoked Response (product code GWF), Class II - Special Controls.

Submitted by Magstim Company Us, LLC (Woburn, US). The FDA issued a Cleared decision on September 26, 2006 after a review of 182 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1870 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Magstim Company Us, LLC devices

FDA 510(k) Submission Details - K060847

510(k) Number K060847 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2006
Decision Date September 26, 2006
Days to Decision 182 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
34d slower than avg
Panel avg: 148d · This submission: 182d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWF Device Classification - Class 2, Special Controls

Product Code GWF Stimulator, Electrical, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWF Stimulator, Electrical, Evoked Response

All 83
Devices cleared under the same product code (GWF) and FDA review panel - the closest regulatory comparables to K060847.
COILS, MODELS MCF-B65, MCF-75, MCF-125 AND COOL-B65
K071821 · Tonica Elektronik A/S · Jul 2007
MODIFICATION TO NUVASIVE NEUROVISION JJB SYSTEM
K062765 · Nuvasive, Inc. · Jan 2007
MAGPRO, MODEL R30
K061645 · Tonica Elektronik A/S · Oct 2006
MEE-1000A NEUROMASTER
K051178 · Nihon Kohden America, Inc. · Aug 2005
MODIFICATION TO: NUVASIVE NEUROVISION JJB SYSTEM
K051384 · Nuvasive, Inc. · Jul 2005
TES-1 CONSTANT VOLTAGE ELECTRICAL STIMULATOR
K042350 · Cadwell Laboratories, Inc. · Nov 2004